US Stock MarketDetailed Quotes

INDP Indaptus Therapeutics

Watchlist
  • 1.020
  • -0.010-0.97%
Close Nov 29 13:00 ET
  • 1.020
  • 0.0000.00%
Post 17:01 ET
12.25MMarket Cap-600P/E (TTM)

Indaptus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.04%3.14M
17.56%4.11M
-11.49%3.94M
9.84%16.38M
2.27%4.18M
19.59%4.25M
-9.67%3.5M
30.95%4.46M
92.92%14.91M
26.99%4.09M
Selling and administrative expenses
-17.10%1.68M
18.87%2.39M
-8.67%2.35M
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
-General and administrative expense
-17.10%1.68M
18.87%2.39M
-8.67%2.35M
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
Research and development costs
-34.16%1.47M
15.77%1.71M
-15.36%1.59M
20.51%7.62M
6.42%2.03M
38.34%2.23M
-1.70%1.48M
44.93%1.88M
150.66%6.32M
102.39%1.91M
Operating profit
26.04%-3.14M
-17.56%-4.11M
11.49%-3.94M
-9.84%-16.38M
-2.27%-4.18M
-19.59%-4.25M
9.67%-3.5M
-30.95%-4.46M
-92.92%-14.91M
-26.99%-4.09M
Net non-operating interest income expense
Other net income (expense)
-77.60%73.02K
-62.58%93.62K
-32.37%136.56K
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
588.11K
431.25K
Other non- operating income (expenses)
-77.60%73.02K
-62.58%93.62K
-32.37%136.56K
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
--588.11K
--431.25K
Income before tax
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
Income tax
Net income
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
Net income continuous Operations
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
Minority interest income
Net income attributable to the parent company
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
Basic earnings per share
31.91%-0.32
-20.51%-0.47
11.76%-0.45
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
Diluted earnings per share
31.91%-0.32
-20.51%-0.47
11.76%-0.45
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.04%3.14M17.56%4.11M-11.49%3.94M9.84%16.38M2.27%4.18M19.59%4.25M-9.67%3.5M30.95%4.46M92.92%14.91M26.99%4.09M
Selling and administrative expenses -17.10%1.68M18.87%2.39M-8.67%2.35M1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M
-General and administrative expense -17.10%1.68M18.87%2.39M-8.67%2.35M1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M
Research and development costs -34.16%1.47M15.77%1.71M-15.36%1.59M20.51%7.62M6.42%2.03M38.34%2.23M-1.70%1.48M44.93%1.88M150.66%6.32M102.39%1.91M
Operating profit 26.04%-3.14M-17.56%-4.11M11.49%-3.94M-9.84%-16.38M-2.27%-4.18M-19.59%-4.25M9.67%-3.5M-30.95%-4.46M-92.92%-14.91M-26.99%-4.09M
Net non-operating interest income expense
Other net income (expense) -77.60%73.02K-62.58%93.62K-32.37%136.56K62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K588.11K431.25K
Other non- operating income (expenses) -77.60%73.02K-62.58%93.62K-32.37%136.56K62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K--588.11K--431.25K
Income before tax 21.76%-3.07M-23.73%-4.02M10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M
Income tax
Net income 21.76%-3.07M-23.73%-4.02M10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M
Net income continuous Operations 21.76%-3.07M-23.73%-4.02M10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M
Minority interest income
Net income attributable to the parent company 21.76%-3.07M-23.73%-4.02M10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.76%-3.07M-23.73%-4.02M10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M
Basic earnings per share 31.91%-0.32-20.51%-0.4711.76%-0.45-5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.44
Diluted earnings per share 31.91%-0.32-20.51%-0.4711.76%-0.45-5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data